RespireRx Pharmaceuticals Inc (RSPI)

[haysaw]

I see it was Targacept's other compound (AZD-3480) which partner AstraZeneca decided not to advance further in ADHD. But now Targacept is advancing their unpartnered TC-5619 in ADHD by themselves. So good news for Cortex indirectly since, as you said, it shows renewed pharma interest in non-stimulant approaches to ADHD, and also the nicotinic approach is a totally new mechanism, so that's another positive.

Plenty of incomplete and misleading information above. AZ and TRGT were partnered up with TC-5619 for ADHD, but the PhII study failed, and AZ decided they did not want to have anything else to do with the molecule. I hope you go well beyond Neuro's input with your own DD.

As far as this development being good news for Corx...I just have to laugh (ha).

Oops, here I go "stirring up the pot" again. Wish I had a more profound purpose, instead of simply being a troublemaker for the sake of trouble. You nailed it on that other board, dude! Ha!

Btw-It appears as though this board needs an MOD. You game? I encourage you, for sure, as you seem to be a big proponent of freedom of speech/lack of censorship.